~~<i id='948FF62D80'><strike id='948FF62D80'><tt id='948FF62D80'><pre id='948FF62D80'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

knowledge

leisure time

author：hotspot 2025-09-28 09:17:18 - browse：7197

Adam's take main illustration — Molly Ferguson/STAT

I was wrong about Geron.

For years, I’ve believed — and declared publicly — that Geron’s effort to develop a blood cancer drug called imetelstat would end in disappointment. The drug was never getting approved, I said.

On Thursday, a group of outside experts convened by the Food and Drug Administration voted 12-2 in imetelstat’s favor, concluding the drug’s benefits outweighed its risks for the treatment of patients with myelodysplastic syndrome. The strong endorsement makes an FDA approval highly likely. The decision is expected on or before June 16.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Affirmative action in medical school literally saved lives
Next article： Brain worms: The science behind RFK Jr.'s parasitic infection

focus

leisure time

entertainment

hotspot

Medicarelaidoutinthegreatestdetailyethowitwillchoosewhichdrugpricesitwillnegotiateinitsbrand-newprog

WSS

Telehealth startups turn to complex chronic diseases

How to make Best Hospitals ratings actually useful for patients

How to make Best Hospitals ratings actually useful for patients

Elevance, private equity launch primary care company

In science, is the line between industry and academia shifting?

In science, is the line between industry and academia shifting?

knowledge

leisure time

focus

23andMe had bad news about my health. I wish a person had delivered it

NYU Langone launches private ChatGPT for its health care data

BioMarin wins approval for gene therapy to treat hemophilia A

Making AI in medicine accessible to smaller, and rural hospitals

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

CDC wastewater surveillance dashboard to track bird flu hotspots

Heart attack and stroke risk calculators need revising

Study: Adult vaccinations pay for themselves in societal benefits

Heart attack and stroke risk calculators need revising

2024 GOP presidential candidates spar over abortion in debate

leisure time

Departing Stanford president retracts two papers

Software glitch causes Tandem insulin pump to shutdown, FDA warns

CDC advisory panel says seniors 'may' get RSV vaccine

2024 GOP presidential candidates spar over abortion in debate

CDC advisory panel says seniors 'may' get RSV vaccine

Apple Watch's A

entertainment

entertainment

hotspot

hotspot